Analystreport

Adverum Biotechnologies, Inc. (NASDAQ: ADVM) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating.

Adverum Biotechnologies, Inc.  (ADVM) 
Last adverum biotechnologies, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: adverum.gcs-web.com/investor-overview